ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Auto Week: Carmakers Dominate a Busy Earnings Slate

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

The auto sector owns this week's earnings calendar. From Tokyo to Mumbai, carmakers report in the next four days against a backdrop of sharply mixed registration data.

Ferrari kicks off today. Austrian car registration data, a leading indicator for Ferrari revenue, is running 75% below last year's comparable quarter. That is a notable signal heading into the print.

Honda reports Thursday. Japanese car sales data, which has a strong historical fit as a revenue lead, is running 10% below the same quarter last year. Polestar, also reporting Thursday, faces a split read. Dutch registrations point 68% lower year-on-year. German registrations point 32% higher. The divergence makes the print hard to call.

Renault reports Wednesday. Its Austrian registration signal is up 6% on last year. Dutch figures point the other way, down 21%.

Grab reports today. The Southeast Asia super-app carries an $11.7bn market cap into results. Singapore visitor arrivals from China hit a six-year September high, a tailwind for the region's consumer economy.

Away from autos, MSCI index changes loom. Moderna holds an 88% probability of rejoining the MSCI World index, with a potential forced buy of $5.9bn. The announcement lands 11 November. Flutter Entertainment and Textron face 70% and 69% deletion odds respectively, with forced selling of $786m and $1.1bn estimated.

No IPOs are scheduled in the next seven days.

Stocks in this article

How this article was generated

Generated
3 Nov 2026, 08:30
Prompt version
v1.0
Data sources
EarningsAlt DataIndex Rebalance

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.